Fulcrum Therapeutics, Inc. (FULC) NASDAQ

8.95

-0.09(-1.00%)

Updated at October 23 04:00PM

Currency In USD

Valuation

Market Cap291.32M
Enterprise Value241.74M
P/E Ratio-7.65
PEG Ratio0
Price/Sales Ratio0
Price/Book Ratio2.61
Enterprise/Revenue0
Enterprise/EBITDA-5.5

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.32
Return On Equity-0.31

Income Statement

Revenue80M
Revenue/Share0
Gross Profit78.41M
EBITDA-18.24M
Net Income-9.73M
Diluted EPS-0.17

Balance Sheet

Total Cash214.11M
Total Cash/Share3.42
Total Debt7.57M
Total Debt/Equity0.04
Current Ratio24.42
Book Value Per Share3.43

Price History

52-Week Change176.23
52-Week High9.89
52-Week Low2.32
Moving Average 50 Days7.89
Moving Average 200 Days5.79

Statistics

Average Volume628,467
Shares Outstanding54.09M
% Held by Institutions86.98

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A